This webinar will explain both common pitfalls that sponsors experience and how clinical pharmacology study execution and operational support can increase the efficiency of your Phase 1 studies and improve the quality of data collected.
This webinar will explain lessons learned from preparing for and responding to viral outbreaks such as H5N1 and pH1N1 influenza and discuss how insights from model-informed drug development approaches can spur access to medicines for patients.
Dr. Steven Kern - Deputy Director of Quantitative Sciences - Bill & Melinda Gates Foundation,
Dr. Craig Rayner - President of Integrated Drug Development - Certara
Dr. Fran Brown - SVP of Integrated Drug Development - Certara